Publication | Closed Access
[Clinical outcome 6 years after autologous hematopoietic stem cell transplantation in multiple sclerosis].
27
Citations
0
References
2008
Year
AHSCT cannot be deemed a curative treatment but may cause prolonged stabilisation or change the aggressive course of the disease.